358 results on '"Huang, Meijin"'
Search Results
2. Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy alone for patients with locally advanced rectal cancer: a propensity-score-matched analysis combined with SEER validation
3. Preservation versus resection of Denonvilliers’ fascia in total mesorectal excision for male rectal cancer: follow-up analysis of the randomized PUF-01 trial
4. Aberrant methylation in neurofunctional gene serves as a hallmark of tumorigenesis and progression in colorectal cancer
5. Accurate tumor segmentation and treatment outcome prediction with DeepTOP
6. Clinical atlas of rectal cancer highlights the barriers and insufficient interventions underlying the unfavorable outcomes in older patients
7. Fasting-mimicking diet synergizes with ferroptosis against quiescent, chemotherapy-resistant cells
8. Single-Agent Neoadjuvant Immunotherapy With a PD-1 Antibody in Locally Advanced Mismatch Repair-Deficient or Microsatellite Instability-High Colorectal Cancer
9. Gamma-glutamyl Transferase to Aspartate Aminotransferase Ratio (GSR) Predicts Prognoses in Patients with Colorectal Cancer with Liver Metastasis after Microwave Ablation
10. Clostridium difficile toxins induce VEGF-A and vascular permeability to promote disease pathogenesis
11. Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trial
12. Morbidity, Mortality, and Pathologic Outcomes of Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer Short-term Outcomes From a Multicenter Randomized Controlled Trial
13. Morbidity, Mortality, and Pathologic Outcomes of Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer Short-term Outcomes From a Multicenter Randomized Controlled Trial
14. Evaluation of transrectal ultrasound-guided tru-cut biopsy as a complementary method for predicting pathological complete response in rectal cancer after neoadjuvant treatment: a phase II prospective and diagnostic trial
15. CagA-positive Helicobacter pylori may promote and aggravate scrub typhus
16. Radiomic signature of the FOWARC trial predicts pathological response to neoadjuvant treatment in rectal cancer
17. Effect of Denonvilliers’ Fascia Preservation Versus Resection During Laparoscopic Total Mesorectal Excision on Postoperative Urogenital Function of Male Rectal Cancer Patients: Initial Results of Chinese PUF-01 Randomized Clinical Trial
18. High platelet-to-lymphocyte ratio predicts improved survival outcome for perioperative NSAID use in patients with rectal cancer
19. The Addition of Preoperative Radiation Is Insufficient for Lateral Pelvic Control in a Subgroup of Patients With Low Locally Advanced Rectal Cancer: A Post Hoc Study of a Randomized Controlled Trial
20. RNA demethylase ALKBH5 promotes colorectal cancer progression by posttranscriptional activation of RAB5A in an m6A‐YTHDF2‐dependent manner
21. Abstract 4147: Activated pyroptosis prior to treatment marks a potential response to immunotherapy in cancers
22. Abstract 6006: RNA m6A methylation relay the oncogenic flow from DNA methylationto gene expression of ANKRD13B
23. Supplementary Data from Epigenetic Inactivation of α-Internexin Accelerates Microtubule Polymerization in Colorectal Cancer
24. Supplementary Table 1 from Epigenetic Inactivation of α-Internexin Accelerates Microtubule Polymerization in Colorectal Cancer
25. Radiological lymph‐node size improves the prognostic value of systemic inflammation index in rectal cancer with pathologically negative nodes
26. Cover Image
27. Clinical characteristics and prognosis of anal squamous cell carcinoma: a retrospective audit of 144 patients from 11 cancer hospitals in southern China
28. Proteome analysis of differential protein expression in porcine alveolar macrophages regulated by porcine reproductive and respiratory syndrome virus nsp1β protein
29. Prevalent Pseudoprogression and Pseudoresidue in Patients With Rectal Cancer Treated With Neoadjuvant Immune Checkpoint Inhibitors
30. PROS1 shapes the immune-suppressive tumor microenvironment and predicts poor prognosis in glioma
31. Silence of a dependence receptor CSF1R in colorectal cancer cells activates tumor-associated macrophages
32. Neoadjuvant Modified FOLFOXIRI With Selective Radiotherapy in Locally Advanced Rectal Cancer: Long-term Outcomes of Phase II Study and Propensity-Score–Matched Comparison With Chemoradiotherapy.
33. CEA clearance pattern as a predictor of tumor response to neoadjuvant treatment in rectal cancer: a post-hoc analysis of FOWARC trial
34. Molecular Typing and Clinical Characteristics of Synchronous Multiple Primary Colorectal Cancer
35. Single-Agent Neoadjuvant Immunotherapy With a PD-1 Antibody in Locally Advanced Mismatch Repair-Deficient or Microsatellite Instability-High Colorectal Cancer
36. DNA methylation profile in CpG-depleted regions uncovers a high-risk subtype of early-stage colorectal cancer
37. Elevated tumor-to-liver uptake ratio (TLR) from 18F–FDG-PET/CT predicts poor prognosis in stage IIA colorectal cancer following curative resection
38. Clinical spectrum of rectal cancer identifies hallmarks of early‐onset patients and next‐generation treatment strategies
39. Neoadjuvant Modified FOLFOXIRI With Selective Radiotherapy in Locally Advanced Rectal Cancer: Long-term Outcomes of Phase II Study and Propensity-Score–Matched Comparison With Chemoradiotherapy
40. Abstract 5272: Aberrant DNA 5mC and 6mA methylations increase ACE2 expression in intestinal cancer cells susceptible to SARS-CoV-2 infection
41. Abstract 5179: Comprehensive characterization of rectal cancer reveals less cancer treatment with worse nutritional status and more comorbidities in the older patients
42. Abstract 5546: Inflamed lymph nodes mark active tumor immune response in colorectal cancer patients
43. Abstract 6079: Spatial deconvolution from bulk DNA methylation profiles determines intratumoral epigenetic heterogeneity
44. The safety assessment of COVID-19 vaccine injection in patients with colorectal cancer.
45. Current Surveillance After Treatment is Not Sufficient for Patients With Rectal Cancer With Negative Baseline CEA
46. Single-agent neoadjuvant immunotherapy of PD-1 antibody in resectable mismatch repair-deficient/microsatellite instability-high colorectal cancer.
47. PD-1 blockade boosted chemo-target therapy in cT4NxM0 pMMR/MSS colorectal cancer.
48. PD-1 blockade combined chemotherapy and bevacizumab in DNA mismatch repair-proficient/microsatellite stable colorectal liver metastases.
49. Molecular typing and clinical characteristics of synchronous multiple primary colorectal cancer.
50. Prognostic value of carcinoembryonic antigen level in patients with colorectal cancer liver metastasis treated with percutaneous microwave ablation under ultrasound guidance
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.